High treatment adherence, satisfaction, motivation, and health-related quality of life with fingolimod in patients with relapsing-remitting multiple sclerosis - results from a 24-month, multicenter, open-label Danish study.

Patient Prefer Adherence · 2018 · PMC6029605 · PMID 29988735

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may be significantno p-value reported

35 In this regard, it should be emphasized that the study includes a limited number of patients and concerns only MS patients treated in Danish MS clinics, and there may be significant differences to other MS clinics with fewer resources to treat these patients.

also in 13,097 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.